Autophagy allows cell survival during starvation through the bulk degradation of proteins and organelles by lysosomal enzymes. However, the mechanisms responsible for the induction and regulation of the autophagy program are poorly understood. Here we show that the FoxO3 transcription factor, which plays a critical role in muscle atrophy, is necessary and sufficient for the induction of autophagy in skeletal muscle in vivo. Akt/PKB activation blocks FoxO3 activation and autophagy, and this effect is not prevented by rapamycin. FoxO3 controls the transcription of autophagy-related genes, including LC3 and Bnip3, and Bnip3 appears to mediate the effect of FoxO3 on autophagy. This effect is not prevented by proteasome inhibitors. Thus, FoxO3 controls the two major systems of protein breakdown in skeletal muscle, the ubiquitin-proteasomal and autophagic/ lysosomal pathways, independently. These findings point to FoxO3 and Bnip3 as potential therapeutic targets in muscle wasting disorders and other degenerative and neoplastic diseases in which autophagy is involved.
INTRODUCTION
Protein degradation in skeletal muscle cells is essentially mediated by the activity of two highly conserved pathways, the ubiquitin-proteasomal pathway and the autophagic/lysosomal pathway. In the first, target proteins are conjugated to multiple ubiquitin moieties and ubiquitin-tagged proteins are degraded within the proteasome complex (Lecker et al., 2006) . In the second, portions of cytoplasm and cell organelles are sequestered into vacuoles, called autophagosomes, with subsequent fusion of autophagosomes with lysosomes and digestion of the content of the vacuoles by lysosomal hydrolases (Lum et al., 2005) . The molecular components of these pathways have been extensively characterized, but the regulatory networks that control their function are still incompletely defined.
The ubiquitin-proteasomal pathway is constitutively operative in normal skeletal muscle and is responsible for the turnover of most soluble and myofibrillar muscle proteins (Lecker et al., 2006) . The activity of this pathway is markedly increased in atrophying muscle due to transcriptional activation of ubiquitin; several proteasomal subunit genes; and two muscle-specific ubiquitin ligases, atrogin-1/ MAFbx and MuRF1, which are induced severalfold during early stages of muscle atrophy (Gomes et al., 2001 ). Importantly, the rate of muscle atrophy is markedly reduced by targeted inactivation of these genes (Bodine et al., 2001a) . Two major signaling pathways appear to control the activation of muscle ubiquitin ligases. One is mediated by the forkhead box O (FoxO) transcription factors, which are normally phosphorylated and inactivated by Akt/PKB but translocate to the nucleus and induce the transcription of both atrogin-1 and MuRF1 in the absence of Akt repression (Sandri et al., 2004; Stitt et al., 2004) . The second regulatory pathway involves the transcription factor NF-kB, which is known to mediate the effect of the cytokine TNF-a in the inflammatory response and which in turn is able to induce the activation of MuRF1 (Cai et al., 2004) .
Autophagy is also constitutively active in skeletal muscle, as shown by the accumulation of autophagosomes seen in human myopathies caused by genetic deficiency of lysosomal proteins, e.g., Pompe's and Danon's diseases, or by pharmacological inhibition of lysosomal function, as in chloroquine myopathy (Shintani and Klionsky, 2004) . Electron microscopic studies have previously shown that autophagy is activated in denervation atrophy (Schiaffino and Hanzlikova, 1972b) and that the lysosomal proteolytic system is stimulated in different conditions leading to muscle atrophy (Bechet et al., 2005) . Autophagy is also induced in skeletal muscle in the immediate postnatal period, when glycogen-filled autophagosomes are especially abundant (Schiaffino and Hanzlikova, 1972a) . The crucial role of autophagy in newborns is demonstrated by the finding that mice deficient in the autophagy genes Atg5 or Atg7 die soon after birth during the critical starvation period when the transplacental nutrient supply is interrupted (Komatsu et al., 2005; Kuma et al., 2004) .
Recently, a fusion protein of GFP with the autophagy protein LC3, the mammalian homolog of the yeast Atg8 gene, has been introduced as a specific marker for autophagosomes . Food deprivation was found to induce the rapid appearance of cytoplasmic fluorescent dots, corresponding to autophagosomes, in fast skeletal muscle of transgenic mice expressing GFP-LC3 . In different cell systems, autophagy is activated by depletion of nutrients or lack of growth factors and, according to current views, this is mediated by the kinase mTOR (Lum et al., 2005) . Autophagy is suppressed by mTOR, which is in turn controlled directly by the level of intracellular amino acids and indirectly by growth factors via Akt/PKB and cell energy status via AMPK. Accordingly, rapamycin, a specific inhibitor of mTOR, activates autophagy. However, autophagy can also be induced by mTOR-independent mechanisms: leucine starvation has been reported to induce mTOR-independent autophagy in cultured myotubes (Mordier et al., 2000) , and mTOR has also been found to be dispensable in other cell systems (Kochl et al., 2006; Sarkar et al., 2007; Yamamoto et al., 2006) . Upregulation of autophagy and lysosomal genes has been documented at the transcript and protein level in different settings, but the mechanisms controlling this transcriptional regulation and their physiological relevance have not been characterized. The lysosomal proteinase cathepsin L is induced in muscle wasting (Sacheck et al., 2007) , and microarray analyses suggest that this is also true for the autophagy-related genes LC3 and Gabarapl1 . Several studies point to upregulation of autophagy genes in other cell systems and in different experimental conditions (Juhasz et al., 2007) . However, the factors involved in the transcriptional regulation of autophagy genes have not yet been identified.
To characterize the mechanisms that control the autophagic/lysosomal pathway during muscle atrophy in vivo, we first identified autophagy-related genes induced in atrophying muscle and determined whether the AktmTOR pathway is involved in the upregulation of some of these genes. Having found that Akt is essential but mTOR is dispensable in suppressing autophagy, we tested the hypothesis that FoxO transcription factors, which play a major role in the activation of the ubiquitin-proteasome system, are also involved in the activation of the autophagic/lysosomal pathway. Gain-and loss-of-function experiments strongly supported a major role of FoxO3, and two targets and mediators of FoxO3, LC3 and Bnip3, were identified. Finally, we addressed the question of whether the induction of autophagy by FoxO3 is secondary to the activation of the ubiquitin-proteasome system and found that the two protein degradation pathways are independently controlled by FoxO3.
RESULTS
Autophagy-Related Genes and Genes Involved in the Regulation of Autophagy Are Induced during Muscle Atrophy The key ubiquitin ligases atrogin-1 and MuRF1 and several other genes of the ubiquitin-proteasome system are upregulated in different models of muscle wasting (Bodine et al., 2001a; Sacheck et al., 2007) . We asked whether the induction of atrophy in skeletal muscle is also accompanied by the upregulation of autophagy-related genes. As shown in Figure 1 , 1 day of fasting induces the transcription of several autophagy-related genes, including two members of the Atg8 family, LC3 and Gabarapl1, as well as Atg4b and some genes involved in the regulation of autophagy, including Vps34 (a class III PI3K), Bnip3, and Bnip3l. Similar changes were observed after 3-day denervation; in this case, two additional autophagy-related genes, Beclin1 and Atg12, were found to be induced (see Figure S1 in the Supplemental Data available with this article online). In agreement with previous studies (Sacheck et al., 2007) , fasting and denervation also induced the lysosomal proteinase cathepsin L (data not shown). Thus, two different models of muscle atrophy led to increased expression of different genes of the autophagic/ lysosomal pathway or genes involved in the regulation of autophagy. Interestingly, four of the most upregulated genes in these models, LC3, Gabarapl1, Bnip3, and Bnip3l, are among the atrophy-related genes (''atrogenes'') induced in other types of muscle wasting .
Autophagy-Related Gene Induction and Autophagosome Formation Are Suppressed by Akt
To identify the signaling pathways responsible for the upregulation of autophagy-related genes, we focused on the role of Akt/PKB, since activation of Akt by growth factors is known to inhibit autophagy in different cell types (Lum et al., 2005) . In skeletal muscle, Akt promotes muscle growth by inducing protein synthesis via mTOR (Bodine et al., 2001b; Pallafacchina et al., 2002) and prevents muscle wasting by blocking proteasome protein breakdown through inhibition of FoxO transcription factors (Sandri et al., 2004) . To assess the effect of Akt activation on autophagy, we generated a transgenic mouse line in which an Akt-estrogen receptor (Akt-ER) fusion protein can be activated in an inducible manner by tamoxifen specifically in skeletal muscle ( Figure S2 ). In control mice, 1 day of fasting caused dephosphorylation of Akt. In contrast, tamoxifen injection caused Akt-ER phosphorylation, as well as phosphorylation of different Akt targets, including FoxOs and the mTOR effectors 4E-BP1 and S6, even during fasting ( Figure 1B ). Adult skeletal muscles were transfected with the GFP-LC3 plasmid to monitor autophagosome formation. In agreement with a previous report , GFP-LC3-positive vesicles were rare in adult muscle of fed mice but increased significantly during fasting ( Figure 1C ; Figure S3 ). It has been reported that LC3-positive dots sometimes represent protein (A) Upregulation of autophagy genes in adult tibialis anterior muscle induced by 1 day of fasting. Quantitative PCR analysis was performed in triplicate using specific oligonucleotides (see Table S1 ). The differences in gene expression levels in control versus fasted animals were statistically significant (*p < 0.001) except for Atg12 and beclin1. Error bars represent SD.
(B) Immunoblotting analysis shows that Akt activation induced by tamoxifen in extensor digitorum longus muscles from Akt transgenic mice (described in Figure S2 ) causes phosphorylation of the Akt targets 4E-BP1, FoxO1, FoxO3, and S6 in muscles from both fed and starved mice. aggregation rather than autophagy (Kuma et al., 2007) . However, we did not observe such structures in muscles from fed animals, even in highly transfected muscle fibers ( Figure 1C ; Figure S3 ). Overexpression of activated Akt in fasting muscle completely abolished the formation of GFP-LC3-positive autophagosomes ( Figure 1C ; Figure S4 ) and the conversion of LC3 from the unlipidated species (LC3-I) to the lipidated species (LC3-II) ( Figure 1D ). Furthermore, Akt prevented the increase in transcript levels of LC3, Gabarapl1, Bnip3, Bnip3l, cathepsin L, and atrogin-1 induced by fasting ( Figure 1E ) or denervation (Figure S5) . These results support the conclusion that Akt has a major role in the transcriptional control of the autophagy program in skeletal muscle in vivo and raise the question of which downstream pathways mediate the effect of Akt. To address this issue, we first examined the role of a major Akt effector, the kinase mTOR, which is known to suppress autophagy in different cell systems.
Autophagy-Related Genes and Autophagic Vesicles Are Not Induced by Rapamycin in Skeletal Muscle
To determine whether the repressive effect of Akt on the fasting-dependent upregulation of autophagy-related genes is mediated by mTOR, we examined the effect of the mTOR inhibitor rapamycin on these genes' expression. As shown in Figure 1E , rapamycin did not reverse the effect of Akt on autophagy-related genes or on cathepsin L and atrogin-1 gene expression. Accordingly, rapamycin did not induce autophagosome formation in Akt transgenic mice or control mice ( Figure 2A ). In our system, rapamycin caused complete dephosphorylation of S6K and S6, as well as 4E-BP1, confirming efficient mTOR inhibition (Figure 2B) . Moreover, rapamycin induced LC3 lipidation in liver, but not in skeletal muscle ( Figure S6 ). To confirm the rapamycin results, we transfected adult muscles with vectors producing shRNAs specific for mTOR. Two different shRNAs effectively knocked down mTOR expression ( Figure 2C ) and caused dephosphorylation of S6, without altering the level of Akt phosphorylation, in transfected muscle fibers of Akt transgenic mice ( Figure 2D ; Figure S7 ). However, autophagosome formation was not induced by RNAi-mediated knockdown of mTOR ( Figure 2E ; Figure S7) , thus confirming the results with rapamycin.
mTOR Controls Autophagy via the mTORC2 Complex
The mTOR kinase is part of two signaling complexes, referred to as mTOR complex 1 (mTORC1), which is rapamycin sensitive and contains raptor, and mTOR complex 2 (mTORC2), which is rapamycin insensitive and contains rictor. Inactivation of mTORC2 induced by rictor knockout has revealed that mTORC2 is required for signaling to Akt-FoxO but not to S6K1, which is a target of mTORC1 (Guertin et al., 2006) . To explore the role of the mTORC2 pathway in skeletal muscle, we used two plasmid vectors producing shRNAs specific for rictor. Both shRNAs knocked down rictor expression ( Figure 2F ) and, when cotransfected in vivo with plasmids coding for FoxO3, induced FoxO3 nuclear translocation in transfected myofibers, supporting the notion that mTORC2 affects FoxO signaling ( Figure 2G ). Accordingly, we observed that RNAi-mediated knockdown of rictor induced a significant increase in autophagosome formation in skeletal muscle ( Figure 2H ) and that this effect was abrogated by constitutively active Akt (ca-Akt) in both the absence ( Figure S8 ) and the presence of rapamycin ( Figure 2I ). Taken together, these results indicate that fasting-induced autophagosome formation and autophagy-gene upregulation are independent of mTORC1 but partially dependent on mTORC2 and suggest that the Akt-FoxO pathway may be involved in the control of autophagy.
FoxO3 Induces Autophagy and Lysosomal Protein Breakdown in Muscle Fibers
To directly determine the role of FoxO transcription factors in autophagy, we first examined the effect of constitutively active FoxO3 (ca-FoxO3) on autophagosome formation, as we had previously shown that ca-FoxO3 causes dramatic muscle atrophy in vivo (Sandri et al., 2004) . Cotransfection with ca-FoxO3 and GFP-LC3 was found to induce a large number of fluorescent puncta in single cultured fibers isolated from adult skeletal muscle, in myofibers of fed live mice as shown by two-photon microscopy, and in muscle sections ( Figures 3A-3C ). Induction of autophagy by ca-FoxO3 was confirmed by electron microscopy of muscles cotransfected with ca-FoxO3 and GFP. By applying a fixation-embedding procedure that allows preservation of GFP fluorescence, we found that transfected fibers were filled with autophagic vacuoles ( Figure 3D ). Atrophic muscle fibers containing accumulations of large autophagosomes were also seen frequently in transfected muscles processed by conventional fixation-embedding procedures ( Figure 3E ), whereas they were not observed in control muscles transfected with GFP plasmids (data not shown). The notion that FoxO3 activates the autophagic/ lysosomal system in skeletal muscle cells is supported by studies on cultured C2C12 muscle cells showing that FoxO3 overexpression markedly increases LC3 lipidation ( Figure 3F ) and that a major fraction (about 70%) of the protein breakdown induced by FoxO3 is lysosomal dependent because it is blocked by concanamycin A, a specific inhibitor of the lysosomal proton pump (Figure 3G ).
FoxO3 Is Required for Fasting-Induced Autophagy
To determine whether FoxO3 is required for the induction of autophagy by fasting, we used a dominant-negative FoxO3 mutant (dn-FoxO3) that was previously found to prevent the upregulation of atrogin-1 and muscle cell atrophy induced by dexamethasone (Sandri et al., 2004) . As shown in Figure 4A , dn-FoxO3 markedly inhibits autophagosome formation induced by fasting in adult skeletal muscle. Similar results were obtained using two different siRNA sequences against FoxO3 ( Figure 4B ). The result of the RNAi experiments was validated by a rescue experiment in which we used a human FoxO3 cDNA. There are (E) Autophagosome formation is not induced by mTOR knockdown. Adult skeletal muscles were transfected with YFP-LC3 and mTOR shRNAs 2 or 3. Vesicles were counted as in Figure 1C .
three mismatches between the mouse FoxO3(2) siRNA sequence and the corresponding human sequence; therefore, human FoxO3 should not be silenced by the mouse siRNA. In fact, cotransfection of human FoxO3 cDNA restored autophagy in muscle fibers in which mouse FoxO3 was knocked down ( Figure 4C ). Since FoxO1 has been reported to inhibit mTOR signaling in skeletal muscle (Southgate et al., 2007) , we explored whether the same is true for FoxO3. However, phosphorylation of S6 was not affected by ca-FoxO3 or dn-FoxO3 ( Figures S9 and S10 ).
FoxO3 Regulates LC3 Gene Expression in Skeletal Muscle
Having shown that FoxO3 is necessary and sufficient for the induction of autophagy, we asked whether FoxO3 is directly involved in the transcriptional regulation of autophagy-related genes and first focused on LC3, a typical autophagy-related gene of the Atg8 family. We identified three putative FoxO binding sites in the promoter region of the LC3 gene. The ability of FoxO3 to bind to the most proximal FoxO site in the LC3 promoter was tested by chromatin immunoprecipitation (ChIP) assays in skeletal muscle nuclei. Overexpressed ca-FoxO3 and endogenous FoxO3 were found to interact with the LC3 promoter ( Figure 5A ; Figure S11 ). Furthermore, fasting increased FoxO3 binding and histone acetylation at this site. To determine the functional role of FoxO3 binding, the region of the LC3 promoter containing the proximal FoxO site was cloned upstream of a minimal SV40 promoter into a luciferase reporter vector and used for in vivo transfection in skeletal muscle. ca-FoxO3 activates the LC3 promoter in transfected muscles, but not the promoter in which the FoxO site was mutated ( Figure 5B ). In contrast, dnFoxO3 strongly inhibited the LC3 promoter ( Figure 5C ), and FoxO3 inhibition by either dn-FoxO3 or RNAi decreased LC3 protein in transfected cells ( Figure 5D ). To determine whether the transcriptional regulation of LC3 by FoxO3 is physiologically relevant, we cotransfected skeletal muscles with ca-FoxO3 and LC3 shRNAs. Muscle atrophy induced by ca-FoxO3 was significantly decreased, but not completely abolished, by LC3 knockdown ( Figure 5E ).
FoxO3-Induced Autophagy Is Modulated by Bnip3
We subsequently focused on Bnip3 and Bnip3l, which are among the most induced atrogenes in different types of muscle wasting and have been shown to control autophagy in other cell systems (Hamacher-Brady et al., 2007; Tracy et al., 2007) . We observed that several potential binding sites for FoxO transcription factors are present in the Bnip3 and Bnip3l promoters and found that FoxO3 binding to Bnip3 and Bnip3l promoters increased in fasting muscle as determined by ChIP experiments (Figure 6A) . The notion that FoxO3 may control the expression of Bnip3 was strongly supported by the finding that caFoxO3 induced Bnip3 and Bnip3l expression ( Figure 6B) . Conversely, FoxO3 inhibition by dn-FoxO3 or shRNAs reduced Bnip3 protein level ( Figure 6C) . Importantly, overexpression of Bnip3 or Bnip3l was sufficient to induce autophagosome formation in normal skeletal muscle ( Figure 6D ). Next, we examined whether Bnip3, which is strongly upregulated in fasting muscle, is required for the induction of the autophagy process. Two siRNA sequences, one of which is shown in Figure 6E and the other of which was reported in a previous study (HamacherBrady et al., 2007) , were used in these experiments. Bnip3 knockdown strongly reduced both the formation of GFP-LC3-positive autophagosomes and LC3 lipidation ( Figures 6F and 6G ) induced by ca-FoxO3 in skeletal muscle. In addition, autophagosome formation induced by fasting was also markedly reduced, though not completely abolished, by Bnip3 knockdown ( Figure 6H ). Thus, Bnip3 induction by FoxO3 appears to play a major role in autophagosome formation during muscle atrophy.
Autophagy Is Not Impaired by Inhibition of the Ubiquitin-Proteasome System FoxO transcription factors are known to control the expression of the ubiquitin ligases atrogin-1 and MuRF1 and the activation of the ubiquitin-proteasome system, a major pathway involved in muscle protein degradation and muscle atrophy (Stitt et al., 2004) . We therefore asked whether the induction of autophagy by FoxO3 is due to a direct effect or is secondary to the activation of the ubiquitin-proteasomal pathway. To determine whether autophagy is dependent on the activity of the muscle-specific ubiquitin ligases, skeletal muscles of atrogin-1 and MuRF1 knockout mice were transfected with GFP-LC3, and 7 days later, the mice were fasted for 24 hr. As shown in Figures 7A and 7B , autophagosome formation was unaffected by loss of these genes. To determine whether autophagy is dependent on proteasome function, we used the proteasome inhibitor MG262. The induction of GFP-LC3-positive autophagosomes by ca-FoxO3 was unaffected by treatment with MG262 ( Figure 7C ). To demonstrate the efficacy of MG262 treatment in blocking proteasome function in vivo, skeletal muscles of control and MG262-treated mice were transfected with the (F) RNAi-mediated knockdown of rictor revealed by immunoblotting. MEFs were transfected with vectors expressing two different shRNAs against rictor. (G) Anti-HA immunostaining shows that FoxO3 is dephosphorylated and is translocated into the nucleus of myofibers of adult muscles transfected with wild-type HA-FoxO3 and pSUPER vectors expressing shRNAs against rictor. (H) Knockdown of rictor activates autophagy in mice. Adult skeletal muscles were cotransfected with YFP-LC3 and shRNAs against rictor. Seven days later, YFP-positive vesicles were quantified. *p < 0.001. (I) Overexpression of constitutively active Akt (ca-Akt) blocks autophagosome formation induced by mTORC2 inhibition. Skeletal muscles of adult transgenic mice were cotransfected with YFP-LC3 and RNAi vectors against rictor. Mice were treated with tamoxifen and with rapamycin as described in Figure 1D . Error bars represent SEM. (A) Isolated single myofibers were transfected with GFP-LC3 and either constitutively active FoxO3 (ca-FoxO3) or mock vector and placed in cell culture. Forty-eight hours later, GFP-positive fibers were analyzed for autophagosome formation by confocal microscopy. (B) Imaging of FoxO3-mediated autophagosome formation in muscles of live mice. Adult tibialis anterior muscle was transfected with GFP-LC3 and either ca-FoxO3 or mock vector. Two weeks later, muscle was exposed and observed in situ using two-photon microscopy as described in Experimental Procedures. (C) Adult muscles were transfected with GFP-LC3 and either ca-FoxO3 or mock vector (control). Two weeks later, muscles were collected and analyzed for fluorescent vesicle formation. short-lived UbG76V-GFP reporter, using cotransfection with histone 2B-RFP to identify transfected fibers (Lindsten et al., 2003) . As shown in Figure 7D , GFP fluorescence was detected in transfected fibers of MG262-treated mice, but not in transfected fibers of control mice, thus confirming that proteasome function is effectively repressed by the inhibitor in vivo. These findings indicate that FoxO3 controls the ubiquitin-proteasomal and autophagic/lysosomal pathways independently.
DISCUSSION
Autophagy is a fundamental mechanism essential for cell survival in all eukaryotic organisms. Cultured mammalian cells die rapidly if autophagy is inhibited following nutrient deprivation or growth-factor withdrawal (Lum et al., 2005) , and mice deficient in the Atg5 or Atg7 autophagy genes do not survive the early neonatal starvation period (Komatsu et al., 2005; Kuma et al., 2004) . However, the mechanisms responsible for the induction and regulation of the autophagy program are poorly understood. In particular, although there is evidence that autophagy genes are upregulated during the activation of the autophagic/lysosomal pathway in different species (see Introduction), the transcription factors responsible for the induction of these genes are unknown. The present study, based primarily on in vivo analyses in skeletal muscle, identifies a FoxO3-Bnip3 pathway as a major player in the transcriptional regulation of autophagy-related genes. The starting point of this investigation was the demonstration that several autophagy-related genes and genes involved in the regulation of autophagy are upregulated in two models of muscle atrophy, fasting and denervation.
The results presented here, based on gain-and lossof-function approaches, show that FoxO3 controls the activation of the autophagic/lysosomal pathway during muscle atrophy in vivo. This conclusion is supported by studies in cultured muscle cells showing that FoxO3 stimulates lysosomal proteolysis by inducing autophagy (Zhao et al., 2007 [this issue of Cell Metabolism]) . A role of FoxO transcription factors in autophagy is also supported by evidence from studies in C. elegans and Drosophila. In RNAi is rescued by overexpression of human FoxO3. Adult skeletal muscles were cotransfected with YFP-LC3, wild-type human FoxO3, and a shRNA specific for mouse FoxO3. Seven days later, mice were fasted for 24 hr. Vesicle formation is detected only in a myofiber positive for FoxO3 (asterisk). Anti-FoxO3 immunofluorescence confirms FoxO3 nuclear translocation during fasting (arrow). Quantification of rescued fibers (shown at right) was performed as described above. *p < 0.001. Error bars represent SEM.
response to nutrient deprivation, nematodes undergo dauer formation, a stage of development arrest, and autophagy genes are essential for dauer formation, which is controlled positively by daf-16 (the C. elegans homolog of FoxO) and negatively by Akt (Melendez et al., 2003) . Accordingly, a recent study has shown that flies that have mutated DFoxO cannot activate autophagy in response to starvation, while DFoxO overexpression is sufficient to activate autophagy (Juhasz et al., 2007) .
FoxO3 was previously shown to control the ubiquitinproteasome pathway by upregulating two crucial ubiquitin ligases, atrogin-1 and MuRF1 (Sandri et al., 2004; Stitt et al., 2004) . We show here that the effect of FoxO3 on autophagy is not affected by deficiency of these two genes or by inhibition of proteasome function, suggesting that FoxO3 controls the two major cellular catabolic pathways, the ubiquitin-proteasomal pathway and the autophagic/ lysosomal pathway, independently. This interpretation is consistent with the finding that proteasome function is not affected by loss of autophagy in the brain (Komatsu et al., 2006) . On the other hand, protein breakdown via the proteasome and lysosome is likely to proceed in a coordinated manner in different models of muscle atrophy, in which the degradation of myofibrillar proteins via the proteasome proceeds in parallel with the disposal of mitochondria and sarcoplasmic reticulum membranes via the autophagic/lysosomal pathway. This could well be explained by the existence of a common transcription factor (B) ca-FoxO3 activates an LC3 promoter-reporter construct, but not a construct in which the FoxO binding site is mutated. A plasmid coding for the region of the LC3 promoter containing the proximal FoxO site or the mutated one linked to a minimal SV40 promoter and a luciferase reporter was transfected into adult tibialis anterior muscle in the presence or absence of ca-FoxO3. A renilla luciferase construct was cotransfected to normalize for transfection efficiency. Eight days later, firefly/renilla luciferase activity was determined. *p < 0.001. Error bars represent SD. (C) The activity of the LC3 reporter is suppressed by dn-FoxO3. Experimental conditions were as in (B). Error bars represent SD. (D) FoxO3 inhibition by RNAi against FoxO3 or by dn-FoxO3 reduces LC3 protein level. MEFs were transfected with either shRNA specific for mouse FoxO3 or a vector expressing dn-FoxO3 and analyzed by immunoblotting against LC3 and FoxO3. Note that the signal with FoxO3 antibodies is decreased by FoxO3 RNAi and increased by overexpression of dn-FoxO3. (E) Muscle atrophy induced by FoxO3 is reduced by LC3 RNAi. Adult skeletal muscles were transfected with shRNA specific for mouse LC3 or GFP with or without HA-tagged ca-FoxO3 and examined after 2 weeks. Cross-sectional area of transfected fibers, identified by anti-HA immunofluorescence, was measured as described previously (Sandri et al., 2004 ). *p < 0.001. Error bars represent SEM. that orchestrates muscle atrophy by controlling both pathways, although other possible mechanisms of interaction between the two pathways remain to be established. Autophagy is a fundamental mechanism of survival during starvation, and the results reported here support a role of FoxO factors as master regulators of the transcriptional adaptations of the organism to starvation. In fact, the increased muscle protein catabolism induced by FoxO3 contributes amino acids that are used for glucose production by the liver, where FoxO1 has been shown to control gluconeogenesis gene expression (Puigserver et al., 2003) .
A surprising finding of this study is that mTOR does not appear to play a significant role in the activation of the autophagic/lysosomal pathway during muscle atrophy. Previous studies have shown that the mTOR inhibitor rapamycin induces autophagy in many cell types (Lum et al., 2005) . However, mTOR-independent autophagy has also been reported in different cell systems, including cultured muscle cells (Kochl et al., 2006; Mordier et al., 2000; Sarkar et al., 2007; Yamamoto et al., 2006) . We found that autophagy is unaffected in skeletal muscle when mTOR activity is blocked by rapamycin or by mTOR knockdown, conditions in which S6 phosphorylation is completely blocked. Furthermore, rapamycin was not able to reverse the inhibitory effect of activated Akt in preventing the upregulation of autophagy-related genes induced by fasting. mTOR is part of two multiprotein complexes: mTORC1, which contains raptor and is rapamycin sensitive, is required for signaling to S6K and 4E-BP1, while mTORC2, which contains rictor, is required for signaling to Akt-FoxO (Guertin et al., 2006) . Our finding that mTORC2 inhibition by RNAi against rictor results in FoxO3 translocation and autophagy induction is consistent with the role of FoxO. The finding that autophagy can be induced by rictor knockdown but not by mTOR knockdown could be explained by the existence of a negative feedback effect of S6K on Akt activity (Aguilar et al., 2007) . Thus, the two mTOR complexes may have opposite effects on Akt activity.
An additional factor that complicates the interpretation of the effect of rapamycin is that long-term rapamycin treatment in vitro can also inhibit the mTORC2 complex in some cell types and thus potentially affect the AktFoxO pathway (Sarbassov et al., 2006) . This raises the possibility that, under certain circumstances, rapamycin may induce autophagy not through a direct effect-e.g., by blocking mTOR phosphorylation of specific components of the autophagy machinery-but through an indirect transcriptional effect by inhibiting Akt and thus derepressing FoxO. However, in our in vivo system, rapamycin treatment did not affect Akt phosphorylation ( Figure 2B ) but blocked mTORC1, as revealed by S6K and S6 dephosphorylation. The discrepancy between the results presented here and previous studies with respect to the role of mTOR in autophagy might also reflect the slower pace of autophagy in vivo, based on transcription-dependent regulation via FoxO3, compared to the rapid pace of autophagy in some in vitro systems, based on transcription-independent regulation via mTOR. The complexity of the regulatory networks controlling autophagy is also illustrated by the paradoxical and still unexplained finding that Vps34 has been suggested to be a positive effector in both autophagy and mTORC1 signaling (Nobukuni et al., 2007) .
The mechanism of FoxO3 effect on autophagy remains to be determined; however, our results on the transcriptional regulation of the autophagy-related gene LC3 and the autophagy-regulatory genes Bnip3 and Bnip3l suggest that FoxO3 could act in two ways. The upregulation of LC3 is unlikely to be relevant to the induction of autophagy but is likely to be important for the maintenance of this process. In agreement with previous studies , we found that autophagosome formation is not induced by overexpression of GFP-LC3 in fed mice; therefore, LC3 induction per se is not sufficient to trigger autophagy. On the other hand, since LC3 is continuously consumed during the activation of the autophagic/lysosomal pathway that occurs in muscle atrophy, it is likely that the upregulation of LC3 is required to replenish the LC3 protein pool and thus allow the progression of autophagy. LC3 inhibition by RNAi partially blocks muscle atrophy, confirming that autophagy contributes to muscle atrophy and that upregulation of LC3 is physiologically important. In contrast, the upregulation of Bnip3 has a major role in mediating the effect of FoxO3, as shown by the findings that (1) the binding of FoxO3 to the Bnip3 and Bnip3l promoters is increased in fasted muscle, (2) autophagosome formation is induced in normal muscle in vivo by Bnip3 or Bnip3l overexpression, and (3) the induction of autophagy by ca-FoxO3 is markedly decreased by Bnip3 knockdown. The fact that autophagosome formation is not completely abolished by Bnip3 RNAi could be due to the presence of Bnip3l. Bnip3 is a Bcl-2-related BH3-only protein that is induced by hypoxia in cultured cardiomyocytes (Kubasiak et al., 2002) and ischemic regions of tumors (Okami et al., 2004) and was initially implicated in cell death. However, Bnip3 is now emerging as a central player in autophagy signaling. Bnip3 inhibition using a dominant-negative Bnip3 mutant blocks autophagy in cardiomyocytes during ischemia-reperfusion injury (HamacherBrady et al., 2007) , and knockdown of Bnip3 blocks autophagy in hypoxic tumor cells (Tracy et al., 2007) . Conversely, overexpression of Bnip3 increases autophagy in these same cell systems (Hamacher-Brady et al., 2007; Tracy et al., 2007) . In agreement with the results presented here, Bnip3l has been shown to be under the control of FoxO3 in breast cancer cell lines (Real et al., 2005) .
In conclusion, our results point to a FoxO3-Bnip3 pathway as a major regulatory pathway of autophagy in skeletal muscle in vivo. Since autophagy is implicated in a variety of pathological processes, a better understanding of the regulatory role of FoxO3 and Bnip3 in autophagy in different cell systems will be important for the treatment of not only muscle wasting disorders but also other diseases, including cancer and neurodegenerative diseases.
EXPERIMENTAL PROCEDURES Animals and In Vivo Transfection Experiments
Experiments were performed on adult CD1 mice. The inducible transgenic mice are described in Figure S2 . In vivo transfection experiments were performed as described previously (Sandri et al., 2004) . In some experiments, mice were injected intraperitoneally (i.p.) with 4 mg/kg rapamycin as described previously (Pallafacchina et al., 2002) . Mice transfected with the UbG76V-GFP reporter were treated for 4 days with a daily i.p. injection of 150 ml of MG262 (5 mmol/kg) or vehicle only (30% DMSO in 0.9% NaCl).
Plasmids and Antibodies
See Supplemental Experimental Procedures.
Gene Expression Analyses
Total RNA was prepared from skeletal muscle using the Promega SV Total RNA Isolation kit. Complementary DNA generated with Invitrogen SuperScript III reverse transcriptase was analyzed by quantitative realtime RT-PCR using the QIAGEN QuantiTect SYBR Green PCR kit. All data were normalized to b-actin or GAPDH expression. Oligonucleotide primers used are listed in Table S1 .
Immunoblotting
Frozen skeletal muscle was pulverized by pestle and mortar, lysed, and immunoblotted as described previously (Sandri et al., 2004) . Blots were stripped using Restore western blotting stripping buffer (Pierce) and reprobed if necessary. Antibodies used are listed in Supplemental Experimental Procedures.
Fluorescence Microscopy and Electron Microscopy
Cryosections of muscle transfected with GFP-LC3 were examined using a fluorescence microscope, and fluorescent dots were counted as described previously, normalizing for cross-sectional area . For electron microscopy, we used both conventional fixation-embedding procedures and another procedure based on fixation in paraformaldehyde-glutaraldehyde without osmium and embedding in LR White resin, which allows preservation of GFP fluorescence in semithin 1 mm sections and subsequent analysis of serial thin sections by electron microscopy (Luby-Phelps et al., 2003) .
In Vivo Imaging via Two-Photon Microscopy
To monitor autophagosome formation in situ in living animals, muscles were transfected with GFP-LC3 probe, and two-photon microscopy was performed 2 weeks later upon in situ exposure of transfected muscles as described previously (Tothova et al., 2006) .
Single-Fiber Analyses
Flexor digitorum brevis muscles from adult mice were digested in type I collagenase at 4 C for 1 hr, at 37 C for 2 hr, and dissociated into single fibers. The fibers were electroporated using a BTX porator (50 volts/4 mm, 3 pulses, 200 ms intervals) to transfer plasmid DNA and then plated on glass coverslips coated with laminin and cultured in Tyrode's salt solution (pH 7.3) containing 10% fetal bovine serum, 50 U/ml penicillin, 50 mg/ml streptomycin, and 5% CO 2 (37 C).
Protein Breakdown Assay C2C12 myotubes were incubated with [ 3 H]tyrosine 24 hr before infection and then infected with control or ca-FoxO3 virus for 24 hr. After the chase period, new medium containing concanamycin A (0.1 mM) was added, and proteolysis was measured starting 1 hr later (Sacheck et al., 2004) . Each point is the average of four plates.
In Vivo RNAi
In vivo RNAi experiments were performed as described previously (Sandri et al., 2004 ) using at least two difference sequences for each gene. Sequences and plasmids used are listed in Supplemental Experimental Procedures and Table S2 . For the validation of shRNA constructs, murine embryonic fibroblasts (MEFs) were maintained in DMEM/10% FBS and transfected with shRNA constructs using Lipofectamine 2000 (Invitrogen). Cells were lysed 72 hr later, and immunoblotting was performed as described above.
ChIP Assays and Promoter Analyses
We performed ChIP assays on adult skeletal muscle using the Chromatin Immunoprecipitation (ChIP) assay kit (Upstate). Oligonucleotide primers used are listed in Table S3 . The LC3 mouse genomic DNA fragment (À1608 to À1379) was amplified by PCR with the same primers and inserted into the KpnI and XhoI sites of pGL3-Promoter vector (Promega). Mutations in the FoxO binding site were generated by PCR using the QuikChange technique (Stratagene) with the primers listed in Table S3 . These constructs were transfected into tibialis anterior muscles together with a renilla luciferase vector (pRLTK) to normalize for transfection efficiency as described previously (Sandri et al., 2004) .
Supplemental Data
Supplemental Data include Supplemental Experimental Procedures, three tables, and eleven figures and can be found with this article online at http://www.cellmetabolism.org/cgi/content/full/6/6/458/ DC1/.
